HemaClear® to Exhibit at 22nd Annual Baltimore Limb Deformity Course

OHK Medical Devices, the producer of the single-use, sterile tourniquet device, Hemaclear®; will exhibit at the 22nd Annual Baltimore Limb Deformity Course. This will be the first time Hemaclear® is formally presented to Pediatric Orthopedic Surgeons. The meeting will occur August 31st through September 2nd 2012, at the Baltimore Marriott waterfront hotel.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Hemaclear

I can’t see how it’s not the tourniquet of choice at every hospital

Baltimore, Maryland (PRWEB) August 31, 2012

OHK Medical Devices, the producer of the single-use, sterile tourniquet device, Hemaclear®; will exhibit at the 22nd Annual Baltimore Limb Deformity Course. This will be the first time Hemaclear® is formally presented to Pediatric Orthopedic Surgeons. The meeting will occur August 31st through September 2nd 2012, at the Baltimore Marriott waterfront hotel. Hemaclear® is the safest choice for pediatric procedures, and the team at OHK Medical Devices is happy to present it to the best Pediatric Orthopedic Surgeons.

Since the launch of Hemaclear® more then 500,000 tourniquets have been safely and successfully applied in a variety of orthopedic cases. The novel tourniquet device is quickly becoming the standard of care in pediatric limb deformity procedures. “I can’t see how it’s not the tourniquet of choice at every hospital,” said Dr. Shawn C. Standard, MD, Head of Pediatric Orthopedic Surgery at Sinai Hospital of Baltimore. Hemaclear® enables pediatric surgeons to perform a greater number of procedures bloodlessly due to an increased surgical field.

About HemaClear®

HemaClear® is the original developer of sterile, single use surgical tourniquet technology that has been adopted as the new standard of care in orthopedic surgery across North America and Europe. By enabling bloodless procedures, reducing infection rates, and increasing the surgical field, the technology makes surgery easier to perform, cheaper to administer, and altogether safer for patients. Healthcare professionals are able to apply the tourniquet in seconds, eliminating obsolete equipment, saving as much as 15 minutes of critical OR setup time, and cutting $300 on every procedure.

In fact, HemaClear is so revolutionary, it represents the single greatest advance in tourniquet technology since the Esmarch bandage. HemaClear® has been proven successful and medically safe worldwide in over 500,000 surgical cases, both in the operating room and in the field, including disaster-struck areas across the world.

Founded in 1999 by an international team of medical specialists and engineers, HemaClear is privately held and based in Haifa, Israel, with offices in 30 countries serving over 2000 operating rooms worldwide. For more information about HemaClear, visit http://www.hemaclear.com


Contact